- Electronic effects and conjugation influencing antioxidant and radicalscavenging capacity
Key Developments 2025-2026: April 2026: Pharmaceutical companies advanced next-generation GLP-1 and dual agonist therapies, focusing on improved glycemic control, weight management benefits, and reduced dosing frequency to enhance patient adherence
This leads to endothelial dysfunction from augmented ROS production, inflammation, and eNOS deletion (88)
At times, human varicose and telangiectatic vessels are noted to sclerose focally after the injection of various solutions
Data availability All data generated in this study are provided in the Supplementary Information and the Source Data files published alongside this article
Having too many free radicals and too few antioxidants in your body causes chemical reactions that damage cells, organs, and tissues